Cargando…
Selective anti-cancer agents as anti-aging drugs
Recent groundbreaking discoveries have revealed that IGF-1, Ras, MEK, AMPK, TSC1/2, FOXO, PI3K, mTOR, S6K, and NFκB are involved in the aging process. This is remarkable because the same signaling molecules, oncoproteins and tumor suppressors, are well-known targets for cancer therapy. Furthermore,...
Autor principal: | Blagosklonny, Mikhail V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912031/ https://www.ncbi.nlm.nih.gov/pubmed/24345884 http://dx.doi.org/10.4161/cbt.27350 |
Ejemplares similares
-
Validation of anti-aging drugs by treating age-related diseases
por: Blagosklonny, Mikhail V.
Publicado: (2009) -
Koschei the immortal and anti-aging drugs
por: Blagosklonny, M V
Publicado: (2014) -
Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021) -
Rejuvenating immunity: “anti-aging drug today” eight years later
por: Blagosklonny, Mikhail V.
Publicado: (2015) -
From rapalogs to anti-aging formula
por: Blagosklonny, Mikhail V.
Publicado: (2017)